2030 年 3D 细胞培养支架市场预测：按类型、用途和地区分類的全球分析

根据 Stratistics MRC 的数据，全球 3D 细胞培养支架市场预计在预测期内将以 17.0% 的年复合成长率成长。

涉及三维（3D）细胞培养支架或基质的製造、销售和应用的全球产业被称为「3D细胞培养支架市场」。这些支架为细胞在三个维度上的发育、增殖和分化提供了有利的环境，与活体组织和器官中的条件非常相似。该市场包括各种合成聚合物、去细胞组织、水凝胶以及用于製造这些 3D 结构的其他材料和技术。

根据美国国立卫生研究院的数据，2020 年各种生物工程技术的总投资达 5,646 美元，高于 2019 年的 5,091 美元。根据美国卫生资源与服务管理局网站「organdonor.gov」显示，截至2021年10月，2020年美国等待器官移植的患者人数为107,103人。

再生医学及组织工程

人们对再生医学和组织工程应用的兴趣日益浓厚，为 3D 细胞培养支架促进生产用于移植的功能性组织和器官提供了机会。此外，药物开发中对更可靠的体外模型的需求不断增长，并且有机会建立更好的预测工具来测试药物功效和安全性。

成本、标准化和复杂性

由于支架材料和技术多种多样，很难为使用 3D 细胞培养支架的研究创建标准化方案。然而，由于它们比传统的 2D 培养技术更昂贵，因此3D 细胞培养支架和相关技术可能不会被广泛使用，特别是在资源有限的环境中。

技术和癌症研究的进步

随着 3D 细胞培养技术（包括基于支架的方法）的不断发展，体外细胞模型的准确性和生理有效性正在提高，从而增加了对支架的需求。此外，在癌症研究和药物试验中，基于支架的 3D 细胞培养模型可以实现更复杂、更真实的肿瘤模型，从而带来更好的治疗方法。

法规墙

我们的 3D 细胞培养支架业务受到法规延误和成本增加的影响，特别是在用于药物测试和安全评估时。复杂的法规可能适用于 3D 细胞培养模型的使用，特别是在药物开发和毒性测试中。遵守这些法规并获得必要的核准可能需要大量的资源和时间。

新冠肺炎 (COVID-19) 影响：

由于全球供应线中断，疫情影响了製造 3D 细胞培养支架的基本材料和组件的供应。结果，製造商遭遇了延误和成本增加。由于经济不确定性，疫情期间研发部门的预算限制可能影响了 3D 细胞培养支架的投资。

合成聚合物领域预计将在预测期内成为最大的领域

预计合成聚合物领域在预测期内将占据最大份额。合成聚合物领域是 3D 细胞培养支架市场的关键结构要素，提供各种具有特定品质的工程材料，用于开发 3D 细胞培养环境。此外，合成聚合物由于其多功能性和生物相容性而非常重要，可以为个体化治疗创造复杂的细胞培养条件。合成聚合物透过促进功能组织和器官的发育，为推进再生医学提供了机会。

预计生物製药领域在预测期内将出现最高的年复合成长率。

预计生物製药领域的年复合成长率最高。生物製药公司使用 3D 细胞培养支架来加速药物研发发现和开发过程。这些支架能够更准确地模拟体内情况，并能够更准确地评估候选药物的功效和安全性。此外，它对于创建生理上准确的细胞模型以用于毒性、癌症和标靶药物设计的研究至关重要。 3D 细胞培养支架市场正在帮助生物製药公司追求个人化医疗，让他们可以根据个别患者的反应来客製化药物。

占比最高的地区

亚太地区所占比例最高。随着该地区发展成为医疗旅游和高科技医疗服务中心，依赖 3D 细胞培养模型的精准医疗和组织再生变得越来越重要。此外，中国和印度等国家的强劲经济成长正在推动医疗保健和生命科学领域的投资，从而推动对尖端细胞培养技术的需求。

复合年复合成长率最高的地区：

亚太地区预计将快速成长。由于该地区心血管疾病的流行，血管生物学研究和 3D 细胞培养支架的製造正在进行中，以更好地了解这些疾病并制定治疗方法。此外，亚太地区的製药部门正在使用 3D 细胞培养模型来测试心血管疗法并评估它们如何影响血管生物学，以帮助药物开发。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

• 公司简介
  • 其他市场参与者的综合分析（最多 3 家公司）
  • 主要企业SWOT分析（最多3家企业）
• 区域分割
  • 根据客户意愿对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
• 竞争基准化分析
  • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

• 概述
• 利害关係人
• 调查范围
• 调查方法
  • 资料探勘
  • 资料分析
  • 资料检验
  • 研究途径
• 调查来源
  • 主要调查来源
  • 二次调查来源
  • 先决条件

第3章市场趋势分析

• 促进因素
• 抑制因素
• 机会
• 威胁
• 应用分析
• 新兴市场
• 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

• 供应商的议价能力
• 买方议价能力
• 替代的威胁
• 新进入者的威胁
• 竞争公司之间的敌对关係

第5章全球 3D 细胞培养支架市场：依类型

• 纤维
• 水凝胶
• 去细胞支架
• 合成聚合物
• 其他类型

第6章全球 3D 细胞培养支架市场：依应用分类

• 生物製药
• 科学研究
• 血管生物学
• 人体组织工程
• 药物研发发现与开发
• 生物列印
• 其他用途

第7章全球 3D 细胞培养支架市场：依地区

• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙
  • 其他欧洲国家
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 纽西兰
  • 韩国
  • 其他亚太地区
• 南美洲
  • 阿根廷
  • 巴西
  • 智利
  • 南美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 卡达
  • 南非
  • 其他中东和非洲

第8章进展

• 合约、伙伴关係、协作和合资企业
• 收购和合併
• 新产品发布
• 业务扩展
• 其他关键策略

第9章公司简介

• 3D Biotek
• Corning Incorporated
• Greiner Bio-One
• InSphero AG
• Lonza Group
• Merck KGaA
• N3d Bioscience
• Nanofiber Solutions
• Reprocell Incorporated
• Synthecon Incorporated
• TARA Biosystems
• Thermo Fisher Scientific

According to Stratistics MRC, the Global 3D Cell Culture Scaffold Market is expected to grow at a CAGR of 17.0% during the forecast period. The global industry for the manufacture, sale, and application of three-dimensional (3D) cell culture scaffolds or matrices is known as the "3D Cell Culture Scaffold Market." These scaffolds offer an environment that is favorable to cell development, proliferation, and differentiation in three dimensions and closely resembles the circumstances found in living tissues and organs. The market includes a wide range of synthetic polymers, decellularized tissues, hydrogels, and other materials and technologies that are used to produce these 3D structures.

According to the National Institute of Health, in 2020, the total investment in various bio engineering technologies amounted to USD 5,646, an increase from USD 5,091 in 2019. According to the organdonor.gov website of the United States Health Resources and Services Administration, in October 2021, 107,103 patients were on the national organ transplant waiting list in the year 2020.

Market Dynamics:

Driver:

Regenerative medicine and tissue engineering

Opportunities for 3D cell culture scaffolds to promote the production of functional tissues and organs for transplantation are offered by the growing interest in regenerative medicine and tissue engineering applications. Additionally, the market acquires from the growing demand for more reliable in vitro models in drug development, providing the chance to build better prediction tools for testing medication efficacy and safety.

Restraint:

Cost, standardization and complexity

Due to the wide range of scaffold materials and technologies available, creating standardized protocols for 3D cell culture scaffold-based research can be difficult. However, they can be more expensive than conventional 2D culture techniques, 3D cell culture scaffolds and related technologies may not be as widely used, especially in environments with limited resources.

Opportunity:

Technology advancements and cancer research

The accuracy and physiological relevance of in vitro cell models are being improved by ongoing developments in 3D cell culture techniques, including scaffold-based approaches, which are increasing the demand for scaffolds. Additionally, for cancer research and medication testing, 3D cell culture models using scaffolds allow for more complicated and realistic tumor models, which leads to better therapeutic approaches.

Threat:

Regulatory barriers

Regulations can cause delays and higher costs in the 3D cell culture scaffold business, particularly when utilized for drug testing and safety evaluations. Complex regulatory regulations may apply to the use of 3D cell culture models, particularly in drug development and toxicity testing. It can take a lot of resources and time to comply with these rules and get the required approvals.

COVID-19 Impact:

The pandemic affected the availability of essential materials and components needed to produce 3D cell culture scaffolds by disrupting global supply lines. Manufacturers experienced delays and higher expenses as a result. Budget restrictions in the research and development divisions during the pandemic were caused by economic uncertainty, which might have had an impact on investments in 3D cell culture scaffolds.

The synthetic polymers segment is expected to be the largest during the forecast period

Synthetic Polymers segment is expected to hold the largest share over the forecast period. A crucial component of the market for 3D cell culture scaffolds, the synthetic polymer sector provides an extensive range of designed materials with specific qualities for developing three-dimensional cell culture settings. Additionally, in order to create complex cell culture conditions for personalized treatment, synthetic polymers are crucial because of their versatility and biocompatibility. They provide the chance for advancements in regenerative medicine by facilitating the development of functioning tissues and organs.

The biopharmaceutical segment is expected to have the highest CAGR during the forecast period

Biopharmaceutical segment is expected to have the highest CAGR. 3D cell culture scaffolds are used by biopharmaceutical businesses to accelerate the drug discovery and development process. These scaffolds offer a more exact approximation of in vivo circumstances, enabling more accurate efficacy and safety assessments of drug candidates. Additionally, they are crucial in the production of physiologically accurate cell models for inquiries on toxicity, cancer, and the design of targeted medicines. The market for 3D cell culture scaffolds aids biopharmaceutical companies in the pursuit of personalized medicine by enabling them to customize medicines based on individual patient responses.

Region with largest share:

The largest share was held by the Asia-Pacific area. Precision medicine and tissue regeneration, which rely on 3D cell culture models, are becoming more and more important as the area develops as a center for medical tourism and high-tech healthcare services. Additionally, investments in healthcare and life sciences are being fueled by the robust economic growth of nations like China and India, which is raising the demand for cutting-edge cell culture technologies.

Region with highest CAGR:

Asia Pacific region is expected to grow rapidly. The prevalence of cardiovascular disorders in the area has prompted an examination of vascular biology and the creation of 3D cell culture scaffold in an effort to better understand these illnesses and create therapeutic remedies. Moreover, the Asia Pacific region's pharmaceutical sector uses 3D cell culture models to test cardiovascular medications and assess how they affect vascular biology, which helps in drug development.

Key players in the market:

Some of the key players in 3D Cell Culture Scaffold Market include: 3D Biotek, Corning Incorporated, Greiner Bio-One, InSphero AG, Lonza Group, Merck KGaA, N3d Bioscience, Nanofiber Solutions, Reprocell Incorporated, Synthecon Incorporated, TARA Biosystems and Thermo Fisher Scientific.

Key Developments:

In October 2023, Thermo Fisher expands US manufacturing plant to support biologics. The US-based biotechnology and medical equipment company has added multiple biologic manufacturing facilities to accommodate a growing demand for these therapies.

In October 2023, Thermo Fisher Scientific, the world leader in serving science, expanded its manufacturing capacity in St. Louis to support biologic therapies for diseases ranging from cancers to auto immune conditions to rare genetic disorders.

Types Covered:

• Fiber
• Hydrogel
• Decellularized Scaffolds
• Synthetic Polymers
• Other Types

Applications Covered:

• Biopharmaceutical
• Scientific Research
• Vascular Biology
• Tissue Engineering
• Drug Discovery and Development
• Bioprinting
• Other Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options::

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global 3D Cell Culture Scaffold Market, By Type

• 5.1 Introduction
• 5.2 Fiber
• 5.3 Hydrogel
• 5.4 Decellularized Scaffolds
• 5.5 Synthetic Polymers
• 5.6 Other Types

6 Global 3D Cell Culture Scaffold Market, By Application

• 6.1 Introduction
• 6.2 Biopharmaceutical
• 6.3 Scientific Research
• 6.4 Vascular Biology
• 6.5 Tissue Engineering
• 6.6 Drug Discovery and Development
• 6.7 Bioprinting
• 6.8 Other Applications

7 Global 3D Cell Culture Scaffold Market, By Geography

• 7.1 Introduction
• 7.2 North America
  • 7.2.1 US
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 Italy
  • 7.3.4 France
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 Japan
  • 7.4.2 China
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 New Zealand
  • 7.4.6 South Korea
  • 7.4.7 Rest of Asia Pacific
• 7.5 South America
  • 7.5.1 Argentina
  • 7.5.2 Brazil
  • 7.5.3 Chile
  • 7.5.4 Rest of South America
• 7.6 Middle East & Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 UAE
  • 7.6.3 Qatar
  • 7.6.4 South Africa
  • 7.6.5 Rest of Middle East & Africa

8 Key Developments

• 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 8.2 Acquisitions & Mergers
• 8.3 New Product Launch
• 8.4 Expansions
• 8.5 Other Key Strategies

9 Company Profiling

• 9.1 3D Biotek
• 9.2 Corning Incorporated
• 9.3 Greiner Bio-One
• 9.4 InSphero AG
• 9.5 Lonza Group
• 9.6 Merck KGaA
• 9.7 N3d Bioscience
• 9.8 Nanofiber Solutions
• 9.9 Reprocell Incorporated
• 9.10 Synthecon Incorporated
• 9.11 TARA Biosystems
• 9.12 Thermo Fisher Scientific

List of Tables

• Table 1 Global 3D Cell Culture Scaffold Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global 3D Cell Culture Scaffold Market Outlook, By Type (2021-2030) ($MN)
• Table 3 Global 3D Cell Culture Scaffold Market Outlook, By Fiber (2021-2030) ($MN)
• Table 4 Global 3D Cell Culture Scaffold Market Outlook, By Hydrogel (2021-2030) ($MN)
• Table 5 Global 3D Cell Culture Scaffold Market Outlook, By Decellularized Scaffolds (2021-2030) ($MN)
• Table 6 Global 3D Cell Culture Scaffold Market Outlook, By Synthetic Polymers (2021-2030) ($MN)
• Table 7 Global 3D Cell Culture Scaffold Market Outlook, By Other Types (2021-2030) ($MN)
• Table 8 Global 3D Cell Culture Scaffold Market Outlook, By Application (2021-2030) ($MN)
• Table 9 Global 3D Cell Culture Scaffold Market Outlook, By Biopharmaceutical (2021-2030) ($MN)
• Table 10 Global 3D Cell Culture Scaffold Market Outlook, By Scientific Research (2021-2030) ($MN)
• Table 11 Global 3D Cell Culture Scaffold Market Outlook, By Vascular Biology (2021-2030) ($MN)
• Table 12 Global 3D Cell Culture Scaffold Market Outlook, By Tissue Engineering (2021-2030) ($MN)
• Table 13 Global 3D Cell Culture Scaffold Market Outlook, By Drug Discovery and Development (2021-2030) ($MN)
• Table 14 Global 3D Cell Culture Scaffold Market Outlook, By Bioprinting (2021-2030) ($MN)
• Table 15 Global 3D Cell Culture Scaffold Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 16 North America 3D Cell Culture Scaffold Market Outlook, By Country (2021-2030) ($MN)
• Table 17 North America 3D Cell Culture Scaffold Market Outlook, By Type (2021-2030) ($MN)
• Table 18 North America 3D Cell Culture Scaffold Market Outlook, By Fiber (2021-2030) ($MN)
• Table 19 North America 3D Cell Culture Scaffold Market Outlook, By Hydrogel (2021-2030) ($MN)
• Table 20 North America 3D Cell Culture Scaffold Market Outlook, By Decellularized Scaffolds (2021-2030) ($MN)
• Table 21 North America 3D Cell Culture Scaffold Market Outlook, By Synthetic Polymers (2021-2030) ($MN)
• Table 22 North America 3D Cell Culture Scaffold Market Outlook, By Other Types (2021-2030) ($MN)
• Table 23 North America 3D Cell Culture Scaffold Market Outlook, By Application (2021-2030) ($MN)
• Table 24 North America 3D Cell Culture Scaffold Market Outlook, By Biopharmaceutical (2021-2030) ($MN)
• Table 25 North America 3D Cell Culture Scaffold Market Outlook, By Scientific Research (2021-2030) ($MN)
• Table 26 North America 3D Cell Culture Scaffold Market Outlook, By Vascular Biology (2021-2030) ($MN)
• Table 27 North America 3D Cell Culture Scaffold Market Outlook, By Tissue Engineering (2021-2030) ($MN)
• Table 28 North America 3D Cell Culture Scaffold Market Outlook, By Drug Discovery and Development (2021-2030) ($MN)
• Table 29 North America 3D Cell Culture Scaffold Market Outlook, By Bioprinting (2021-2030) ($MN)
• Table 30 North America 3D Cell Culture Scaffold Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 31 Europe 3D Cell Culture Scaffold Market Outlook, By Country (2021-2030) ($MN)
• Table 32 Europe 3D Cell Culture Scaffold Market Outlook, By Type (2021-2030) ($MN)
• Table 33 Europe 3D Cell Culture Scaffold Market Outlook, By Fiber (2021-2030) ($MN)
• Table 34 Europe 3D Cell Culture Scaffold Market Outlook, By Hydrogel (2021-2030) ($MN)
• Table 35 Europe 3D Cell Culture Scaffold Market Outlook, By Decellularized Scaffolds (2021-2030) ($MN)
• Table 36 Europe 3D Cell Culture Scaffold Market Outlook, By Synthetic Polymers (2021-2030) ($MN)
• Table 37 Europe 3D Cell Culture Scaffold Market Outlook, By Other Types (2021-2030) ($MN)
• Table 38 Europe 3D Cell Culture Scaffold Market Outlook, By Application (2021-2030) ($MN)
• Table 39 Europe 3D Cell Culture Scaffold Market Outlook, By Biopharmaceutical (2021-2030) ($MN)
• Table 40 Europe 3D Cell Culture Scaffold Market Outlook, By Scientific Research (2021-2030) ($MN)
• Table 41 Europe 3D Cell Culture Scaffold Market Outlook, By Vascular Biology (2021-2030) ($MN)
• Table 42 Europe 3D Cell Culture Scaffold Market Outlook, By Tissue Engineering (2021-2030) ($MN)
• Table 43 Europe 3D Cell Culture Scaffold Market Outlook, By Drug Discovery and Development (2021-2030) ($MN)
• Table 44 Europe 3D Cell Culture Scaffold Market Outlook, By Bioprinting (2021-2030) ($MN)
• Table 45 Europe 3D Cell Culture Scaffold Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 46 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Country (2021-2030) ($MN)
• Table 47 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Type (2021-2030) ($MN)
• Table 48 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Fiber (2021-2030) ($MN)
• Table 49 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Hydrogel (2021-2030) ($MN)
• Table 50 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Decellularized Scaffolds (2021-2030) ($MN)
• Table 51 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Synthetic Polymers (2021-2030) ($MN)
• Table 52 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Other Types (2021-2030) ($MN)
• Table 53 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Application (2021-2030) ($MN)
• Table 54 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Biopharmaceutical (2021-2030) ($MN)
• Table 55 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Scientific Research (2021-2030) ($MN)
• Table 56 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Vascular Biology (2021-2030) ($MN)
• Table 57 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Tissue Engineering (2021-2030) ($MN)
• Table 58 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Drug Discovery and Development (2021-2030) ($MN)
• Table 59 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Bioprinting (2021-2030) ($MN)
• Table 60 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 61 South America 3D Cell Culture Scaffold Market Outlook, By Country (2021-2030) ($MN)
• Table 62 South America 3D Cell Culture Scaffold Market Outlook, By Type (2021-2030) ($MN)
• Table 63 South America 3D Cell Culture Scaffold Market Outlook, By Fiber (2021-2030) ($MN)
• Table 64 South America 3D Cell Culture Scaffold Market Outlook, By Hydrogel (2021-2030) ($MN)
• Table 65 South America 3D Cell Culture Scaffold Market Outlook, By Decellularized Scaffolds (2021-2030) ($MN)
• Table 66 South America 3D Cell Culture Scaffold Market Outlook, By Synthetic Polymers (2021-2030) ($MN)
• Table 67 South America 3D Cell Culture Scaffold Market Outlook, By Other Types (2021-2030) ($MN)
• Table 68 South America 3D Cell Culture Scaffold Market Outlook, By Application (2021-2030) ($MN)
• Table 69 South America 3D Cell Culture Scaffold Market Outlook, By Biopharmaceutical (2021-2030) ($MN)
• Table 70 South America 3D Cell Culture Scaffold Market Outlook, By Scientific Research (2021-2030) ($MN)
• Table 71 South America 3D Cell Culture Scaffold Market Outlook, By Vascular Biology (2021-2030) ($MN)
• Table 72 South America 3D Cell Culture Scaffold Market Outlook, By Tissue Engineering (2021-2030) ($MN)
• Table 73 South America 3D Cell Culture Scaffold Market Outlook, By Drug Discovery and Development (2021-2030) ($MN)
• Table 74 South America 3D Cell Culture Scaffold Market Outlook, By Bioprinting (2021-2030) ($MN)
• Table 75 South America 3D Cell Culture Scaffold Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 76 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Country (2021-2030) ($MN)
• Table 77 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Type (2021-2030) ($MN)
• Table 78 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Fiber (2021-2030) ($MN)
• Table 79 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Hydrogel (2021-2030) ($MN)
• Table 80 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Decellularized Scaffolds (2021-2030) ($MN)
• Table 81 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Synthetic Polymers (2021-2030) ($MN)
• Table 82 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Other Types (2021-2030) ($MN)
• Table 83 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Application (2021-2030) ($MN)
• Table 84 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Biopharmaceutical (2021-2030) ($MN)
• Table 85 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Scientific Research (2021-2030) ($MN)
• Table 86 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Vascular Biology (2021-2030) ($MN)
• Table 87 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Tissue Engineering (2021-2030) ($MN)
• Table 88 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Drug Discovery and Development (2021-2030) ($MN)
• Table 89 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Bioprinting (2021-2030) ($MN)
• Table 90 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Other Applications (2021-2030) ($MN)